| Multiple Myeloma |
1 |
1 |
| Biologic Therapy |
0 |
0.81 |
| Stem Cell Research and Therapy |
0 |
0.48 |
| Social Determinants of Health |
0 |
0.47 |
| Transplantation |
0 |
0.42 |
| Autologous stem cell transplant |
0 |
0.41 |
| Cell Transplantation |
0 |
0.38 |
| Genomic Medicine |
0 |
0.33 |
| DNA Sequencing |
0 |
0.32 |
| Monoclonal Antibody |
0 |
0.32 |
| Toxicology |
0 |
0.25 |
| Cancer |
0 |
0.21 |
| Hematology |
0 |
0.21 |
| Immunomodulator |
0 |
0.21 |
| Proteasome Inhibitor |
0 |
0.21 |
| Thromboembolism |
0 |
0.19 |
| Septic Shock |
0 |
0.15 |
| Thrombocytopenia |
0 |
0.13 |
| Biomedical Technology |
0 |
0.11 |
| Chemotherapy |
0 |
0.11 |
| Embolism |
0 |
0.11 |
| Glucocorticoid |
0 |
0.11 |
| Medical Oncology |
0 |
0.11 |
| Pulmonary Embolism |
0 |
0.11 |
| Refractory |
0 |
0.11 |
| Residual Disease |
0 |
0.11 |
| Shock |
0 |
0.11 |
| Spine |
0 |
0.11 |
| Steroids |
0 |
0.11 |
| Healthcare and Medical Technology |
0 |
0.08 |
| Neutropenia |
0 |
0.08 |
| Pneumonia |
0 |
0.08 |
| Sepsis |
0 |
0.08 |